Treatment of resistant rheumatoid arthritis with minocycline: an open study.
about
Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure.Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects.Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes.
P2860
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
@en
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
@nl
type
label
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
@en
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
@nl
prefLabel
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
@en
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
@nl
P2093
P1476
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
@en
P2093
P304
P407
P577
1992-10-01T00:00:00Z